Dr. Hicks Professor and Director of IHC-ISH Laboratory and Breast Subspecialty Service at URMC. His innovative approaches to improving efficiency and quality in surgical pathology have been highlighted in publications and invited lectures sponsored by national pathology organizations. He has implemented a subspecialty-based surgical pathology system, combining disease-specific diagnostic and prognostic expertise with translational research based on organ systems and disease categories.
As a member of the Ad Hoc Committee on Immunohistochemistry Standardization, and co-author of their consensus recommendations, he is a leader in the emerging effort to achieve the full potential of immunostaining as a tissue-based quantitative ELISA test. He has been appointed to an ASCO/CAP panel that is developing national guidelines on estrogen receptor testing in breast cancer, having served recently on a similar panel that made important recommendations to improve HER2 testing in breast cancer.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)